InflaRx N.V. IFRX
1.18 USD +0.01 (+0.85%)
Regular-session close
1.18 0.00 0.00%
After hours · Nov 16, 4:00 PM ET
1.15 Day range 1.23
0.798 52-week range 2.95
- YTD
- +16.83%
- 1 year
- -12.59%
News
benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session Gainers InflaRx (NASDAQ:IFRX) stock rose 12.7% to $1.32 during Friday's after-market session. The market value of their outstanding shares is at $182.6 million. Instinct Bio Technical Co…
zacks.com Here's Why InflaRx (IFRX) Is a Great 'Buy the Bottom' Stock Now InflaRx (IFRX) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall…
zacks.com Down 20.3% in 4 Weeks, Here's Why You Should You Buy the Dip in InflaRx (IFRX) The heavy selling pressure might have exhausted for InflaRx (IFRX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts…benzinga.com InflaRx Announces Peer-Reviewed Publication Of First-In-Human Phase 1 Clinical Data For Izicopan, Orally Administered, Next-Gen Small Molecule Inhibitor Of C5a Receptor Izicopan achieved rapid and sustained inhibition of C5a/C5aR1 signalingPharmacokinetic results demonstrated dose-dependent exposure, with izicopan well tolerated across all single and multiple doses…
benzinga.com InflaRx Q3 EPS $(0.02) Beats $(0.07) Estimate InflaRx (NASDAQ:IFRX) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.07) by 71.43 percent. This is a 90.48 percent increase over losses of $(0.21) per…
